Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19, Eosinophils, and Biologicals for Severe Asthma
Carlo Lombardi, Diego Bagnasco, Giovanni Passalacqua
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 10

Showing 10 citing articles:

Eosinophils as potential biomarkers in respiratory viral infections
Iole Macchia, Valentina La Sorsa, Francesca Urbani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Asthma in the era of COVID-19
Sara Assaf, Henning Stenberg, Miloš Jeseňák, et al.
Respiratory Medicine (2023) Vol. 218, pp. 107373-107373
Open Access | Times Cited: 12
Haematological and serum biochemical derangements induced by acute exposure to didecyl dimethyl ammonium bromide in Gallus gallus domesticus
Bello Ayema Abdul, Hamza Ibrahim Isa, Muftau Shittu
Bulletin of the National Research Centre/Bulletin of the National Research Center (2025) Vol. 49, Iss. 1
Open Access
Asthma and COVID-19 (review)
O. S. Kruglova, Е. А. Собко, И. В. Демко, et al.
Bulletin physiology and pathology of respiration (2025), Iss. 95, pp. 135-148
Closed Access
Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety
W. Sahli, Joana Vitte, Benoît Desnues
Clinical and Translational Allergy (2025) Vol. 15, Iss. 3
Open Access
Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
Hitasha Rupani, William W. Busse, Peter Howarth, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2589-2604
Open Access | Times Cited: 3
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study
Sara Manti, Alessandro Giallongo, Giulia Pecora, et al.
Pediatric Pulmonology (2023) Vol. 58, Iss. 4, pp. 1085-1091
Closed Access | Times Cited: 7
Predicting COVID-19 prognosis in hospitalized patients based on early status
David Natanov, Byron Avihai, Erin McDonnell, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 4
COVID-19-Associated Disease Course Is Shortened in Moderate-to-Severe Atopic Dermatitis Patients Receiving Dupilumab Treatment: A Retrospective Cross-Sectional Study
Dongxia Ma, Yin Wang, Nan Huang, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3415-3415
Open Access | Times Cited: 3
Genomic analysis of severe COVID-19 considering or not asthma comorbidity: GWAS insights from the BQC19 cohort
Omayma Amri, Anne‐Marie Madore, Anne‐Marie Boucher‐Lafleur, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access
Page 1

Scroll to top